Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00626834 · ClinicalTrials.gov registry record · Phase 1
Vigabatrin Ph 1 Cocaine Interaction Study
A Phase 1 study of Cocaine Addiction, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT00626834 is a Phase 1 study of Cocaine Addiction that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 24 participants, below the 83-participant average among 5 other Cocaine Addiction trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00626834, a Phase 1 study of Cocaine Addiction, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a Phase 1 safety/tolerably study to determine if there are clinically significant interactions between oral vigabatrin (gamma vinyl-gamma-amino butyric acid; VGB) concurrent with intravenous (IV) cocaine infusions.
Conditions Studied
Interventions
- DRUG Matching placebo
- DRUG Vigabatrin
Study Locations (1)
Texas
- University of Texas Health Science Center - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00626834
The ClinicalTrials.gov registry entry for NCT00626834 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 83-participant average among 5 other Cocaine Addiction trials with a reported enrollment target (71% lower). The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cocaine Addiction appearing as the primary indexed condition, and to 2 interventions - of which Matching placebo is the first listed.
NCT00626834 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00626834 about?
NCT00626834 is a clinical study titled "Vigabatrin Ph 1 Cocaine Interaction Study". This is a Phase 1 safety/tolerably study to determine if there are clinically significant interactions between oral vigabatrin (gamma vinyl-gamma-amino butyric acid; VGB) concurrent with intravenous (IV) cocaine infusions.
What is the current status of trial NCT00626834?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2008-02. Estimated completion is 2010-10.
What conditions does trial NCT00626834 study?
This clinical trial studies the following conditions: Cocaine Addiction.
What interventions are being tested in trial NCT00626834?
The interventions under investigation include: Matching placebo (DRUG), Vigabatrin (DRUG).
Who is sponsoring clinical trial NCT00626834?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00626834 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine Addiction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
COMPLETED · Phase 1
-
Integrative Meditation (IM) for Cocaine Addiction
COMPLETED · NA
-
Exercise as a Behavioral Treatment for Cocaine Dependence
COMPLETED · NA
-
Vigabatrin for the Treatment of Cocaine Dependency
COMPLETED · Phase 2
-
A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.